Replimune Group Inc

Replimune Group Inc

REPL

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.3B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Replimune Group IncReplimune Group Inc-4.9--281%-0.3
$15.50

Target Price by Analysts

3% downsideReplimune Group Target Price DetailsTarget Price
$1.05

Current Fair Value

93.4% downside

Overvalued by 93.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.30 Billion
Enterprise Value$1.14 Billion
Dividend Yield$- (-)
Earnings per Share$-3.38
Beta0.9
Outstanding Shares96,864,452

Return

Return on Equity-281.14%ROE
Return on Assets-117.65%
Return on Invested Capital-137.57%

Valuation & Multiples

P/E Ratio-4.92P/E Ratio
PEG25.2PEG
Price to Sales-Price to Sales
Price to Book Ratio15.98Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-3.89
Enterprise Value to Net Income-4
Total Debt to Enterprise0.02
Debt to Equity0.26Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 14, 2026
EPS Estimate
$-0.69
Average shareholder expectation
Revenue Estimate
$13.60 M
Average shareholder expectation

Next Earnings Call

Expected Date
October 29, 2026
EPS Estimate
$-0.74
Average shareholder expectation
Revenue Estimate
$1.20 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.4358 12.25%
Total Calls5,954,274 6.71%
Total Puts2,594,780 48.42%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %103.55% 15.58%
Total Invested$1.06B 71.96%
Investors Holding226 19.00%

ESG Score

No data

About Replimune Group Inc

CEO: Robert Coffin